论文部分内容阅读
近年来,“互联网+”概念辐射并渗透医药行业,医药电商得到蓬勃发展。然而中国医药零售在医药市场中的占比约为20%,且其中电商占整体医药零售比例不到3%,远远低于欧美市场。中国医药电商理应有很大的发展空间,但现阶段由于市场环境、政策监管壁垒以及消费者行为差异等因素,众多医药企业在探索电商的道路上将面临不少挑战。2016年初,波士顿咨询公司(BCG)对85家医药零售电商企业以及300多位消费者展
In recent years, the concept of “Internet + ” has radiated and penetrated the pharmaceutical industry, and the pharmaceutical electricity supplier has been booming. However, China’s pharmaceutical retail accounts for about 20% of the total pharmaceutical market, and the share of total retail sales of e-commerce accounts for less than 3%, much lower than that of the European and American markets. However, at this stage, many pharmaceutical companies will face many challenges in the exploration of e-commerce due to factors such as market environment, regulatory barriers and differences in consumer behavior. In early 2016, Boston Consulting Company (BCG) evaluated 85 healthcare retailers and more than 300 consumer electronics companies